FILO (field interaction ligand optimization): a simplex strategy for searching the optimal ligand interaction field in drug design.
A method (FILO, Field Interaction Ligand Optimization) for obtaining the optimal molecular interaction field was developed on the basis of the Simplex optimization procedure applied to a matrix of interaction energies obtained by performing a GRID computation on a suitable data set. The FILO procedure was tested on a set of nine HIV-1 protease inhibitors with known crystal structures. The results of FILO consist of the optimal molecular interaction field of a putative new ligand with optimal binding affinity. The final FILO model yields R2 and R2(CV) values of 0.993 and 0.936, respectively, and finds eight negative and four positive interaction nodes for the OH probe taken as an example. The eight H bonding interactions pointed out by FILO identified well the binding site AA-residues Gly A27, Asp A29, water 501, Gly B48 and Asp A25 of HIV-1 protease.
Melani
F
F
Department of Pharmaceutical Science, Firenze University, Italy.
Gratteri
P
P
Adamo
M
M
Bonaccini
C
C
D015195:Drug Design; D017320:HIV Protease Inhibitors / Q000737:chemistry; D006860:Hydrogen Bonding; D008024:Ligands; D008958:Models, Molecular
D017320:HIV Protease Inhibitors; D008024:Ligands